Overview

Study in Participants With Acute Migraines Headaches

Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, randomized, double-blind, placebo and active comparator-controlled study of LY2590443 in approximately 200 participants with migraines.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Sumatriptan